Nested Nanobubbles for Ultrasound-Triggered Drug Release

Abstract

Because of their size (1–10 μm), microbubble-based drug delivery agents suffer from confinement to the vasculature, limiting tumor penetration and potentially reducing the drug efficacy. Nanobubbles (NBs) have emerged as promising candidates for ultrasound-triggered drug delivery because of their small size, allowing drug delivery complexes to take advantage of the enhanced permeability and retention effect. In this study, we describe a simple method for production of nested-nanobubbles (Nested-NBs) by encapsulation of NBs (∼100 nm) within drug-loaded liposomes. This method combines the efficient and well-established drug-loading capabilities of liposomes while utilizing NBs as an acoustic trigger for drug release. Encapsulation was characterized using transmission electron microscopy with an encapsulation efficiency of 22 ± 2%. Nested-NBs demonstrated echogenicity using diagnostic B-mode imaging, and acoustic emissions were monitored during high-intensity focused ultrasound (HIFU) in addition to monitoring of model drug release. Results showed that although the encapsulated NBs were destroyed by pulsed HIFU [peak negative pressure (PNP) 1.54–4.83 MPa], signified by loss of echogenicity and detection of inertial cavitation, no model drug release was observed. Changing modality to continuous wave (CW) HIFU produced release across a range of PNPs (2.01–3.90 MPa), likely because of a synergistic effect of mechanical and increased thermal stimuli. Because of this, we predict that our NBs contain a mixed population of both gaseous and liquid core particles, which upon CW HIFU undergo rapid phase conversion, triggering liposomal drug release. This hypothesis was investigated using previously described models to predict the existence of droplets and their phase change potential and the ability of this phase change to induce liposomal drug release.

Mesenchymal Stem Cells Functionalized Sonodynamic Treatment for Improving Therapeutic Efficacy and Compliance of Orthotopic Oral Cancer

“…Ultrasound is a mechanic wave with high tissue penetration, and has been widely used as a potent stimulus for controllable drug delivery systems. [ 38 ] Particularly, PFC nanodroplets exhibit good phase transition property under ultrasound stimulation due to acoustic droplet vaporization, which is associated with cavitation, mechanical effects, thermal effects, and so on, allowing for noninvasive and precise delivery of drug in diseased tissues. [ 39 ] We therefore investigated the time‐dependent release of oxygen and verteporfin with and without ultrasound stimulation at 37 °C.…”

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue

“…External stimuli-responsive DDS includes release of payload by physical triggers, such as temperature [ 262 , 263 ], electromagnetic stimuli such as photodynamic therapy [ 264 ], ultrasound [ 265 ], electric field [ 266 ], and applied mechanical force [ 267 ]. Jose et al developed temperature-sensitive liposomes encapsulating tamoxifen and imatinib drugs for breast cancer treatment.…”

Current advances in ultrasound-combined nanobubbles for cancer-targeted therapy: a review of the current status and future perspectives

“…91 This led to a three-fold increase in their diameter and promoted the breakdown of the liposome and release of the drugs. 91 Herceptin-conjugated, PTX-loaded, PEGylated PLGA-based magnetic NBs were prepared by Song et al using updated carbodiimide technology and an evaporation procedure of double emulsication. The PTX-USPIO-HER-loaded NBs exhibited a prominent size distribution, superparamagnetism, capacity selection, and USPIO/PTX setting.…”